News
CYRX
--
0.00%
--
R. R. Donnelley & Sons leads industrial gainers; DPW and Cryoport among losers
Gainers: R. R. Donnelley & Sons (RRD) +18%. FreightCar America (RAIL) +14%. RF Industries (RFIL) +13%. Radiant Logistics (RLGT) +11%. Sino-Global Shipping America (SINO) +9%.Losers: DPW Holdings (DPW) -9%. Cryoport (CYRX) -7%. Forterra
Seekingalpha · 09/15 17:03
'Fast Money Halftime Report' Picks For September 3: Lamar, Crowdstrike And More
On CNBC's "Fast Money Halftime Report," Jenny Harrington recommended a long position in Lamar Advertising Co (NASDAQ: LAMR).
Benzinga · 09/03 20:36
Chart Industries Seeing Stable Industrial Trends, With Long-Term LNG Upside
Chart has continued to execute well despite a lot of end-market turbulence, industrial gas revenue declined modestly, and LNG revenue growth offset weak natural gas processing demand.The long-term upside in "Big LNG" remains intact, even if the timing is still highly uncertain, and hydrogen could become a bigger opportunity in the coming years.Chart shares have had an excellent run, but the shares aren't yet at full value.
Seekingalpha · 09/02 19:23
CRM, GTX, PLAN and URBN among midday movers
Gainers: Fluidigm Corporation (FLDM) +33%.SCWorx (WORX) +29%.Anaplan (PLAN) +29%.salesforce.com (CRM) +27%.Cryoport (CYRX) +26%.Lipocine (LPCN) +23%.Immunic (IMUX) +22%.Fluent (FLNT) +22%.BigCommerce Holdings (BIGC) +22%.Urban Outfitters (URBN) +21%.Losers: Garrett Motion (GTX) -42%. Outlook Therapeutics (OTLK)
Seekingalpha · 08/26 16:34
Did Chart Industries do well on its sale of Cryobio?
Sliding 3% on Tuesday after issuing guidance that fell short of consensus estimates, Chart Industries (GTLS) continues to trend lower today, slipping another 1.2% in early trade.Another big announcement yesterday
Seekingalpha · 08/26 14:50
Cryoport (CYRX) Catches Eye: Stock Jumps 9.8%
Zacks · 08/26 12:30
Chart Industries: A Look After A Bolt-On Sale
Chart Industries has announced a divestment, although investors might believe the buying side is the winner here.
Seeking Alpha - Article · 08/26 07:09
Blackstone Just Invested $275 Million in Life Sciences Company Cryoport
The investment will help Cryoport acquire MVE Biological Solutions, which makes products for the life sciences industry.
Barrons.com · 08/26 01:39
Blackstone Invests $275 Million in Life Sciences Firm Cryoport
The investment will help Cryoport acquire MVE Biological Solutions, which makes products for the life sciences industry.
marketwatch.com · 08/26 00:39
Cryoport Announces Agreement to Acquire MVE Biological Solutions from Chart Industries
Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced it has signed an agreement to acquire MVE Biological Solutions ("MVE"), a global leader in manufactured
PR Newswire · 08/25 12:00
Cryoport scoops up Chart's cryobiological products business for $320M
Seeking Alpha - Article · 08/25 11:55
Cryoport Announces Agreement To Acquire MVE Biological Solutions From Chart Industries For $320M In Cash
NASHVILLE, Tenn., Aug. 25, 2020 /PRNewswire/ -- Cryoport, Inc. (NASDAQ:CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life
Benzinga · 08/25 11:07
CryoPort Agrees To Acquire Cryopdp For 49M Euros
CryoPort agreed to acquire logistics solutions provider Cryopdp for approximately 49 million euros in cash sending shares up 14% on Friday.CryoPort (CYRX), a leader in life sciences supply chain solutions, is buying Cryopdp to expand its global supply chain footprint in Europe, the Middle East and Africa
SmarterAnalyst · 08/24 13:59
ShiftPixy leads industrial gainers: Top Ships and India Globalization Capital among losers
Gainers: ShiftPixy (PIXY) +31%. Cryoport (CYRX) +15%. AgEagle Aerial Systems (UAVS) +13%. JanOne (JAN) +12%. Ballard Power Systems (BLDP) +9%.Losers: Top Ships (TOPS) -20%. India Globalization Capital (IGC) -12%. ALJ Regional (ALJJ) -12%.
Seekingalpha · 08/21 17:05
GEVO, GME, TOPS and BKE among midday movers
Gainers: Hancock Jaffe Laboratories (NASDAQ:HJLI) +127%. Harpoon Therapeutics (NASDAQ:HARP) +38%. ShiftPixy (NASDAQ:PIXY) +22%. Velocity Financial (NYSE:VE
Seeking Alpha - Article · 08/21 16:43
Cryoport to acquire CRYOPDP for €49M
Cryoport (NASDAQ:CYRX) signs an agreement to acquire Europe-based CRYOPDP, a global provider of innovative temperature-controlled logistics solutions, in a
Seeking Alpha - Article · 08/21 11:58
Cryoport Expands Global Supply Chain Platform By Signing Agreement To Acquire CRYOPDP
Benzinga · 08/21 11:40
CryoPort EPS misses by $0.04, beats on revenue
CryoPort (NASDAQ:CYRX): Q2 GAAP EPS of -$0.15 misses by $0.04. Revenue of $9.39M (+11.0% Y/Y) beats by $0.46M. Press Release
seekingalpha · 08/07 01:29
Cryoport Reports 2020 Second-Quarter Results
Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a global leader in life sciences supply chain solutions, today announced financial results for Second Quarter and six-month period ended June 30, 2020.
PR Newswire · 08/06 20:05
CryoPort Q2 2020 Earnings Preview
CryoPort (NASDAQ:CYRX) is scheduled to announce Q2 earnings results on Thursday, August 6th, after market close. The consensus EPS Estimate is -$0.11 (-37.
seekingalpha · 08/06 02:35
Webull provides a variety of real-time CYRX stock news. You can receive the latest news about Cryoport through multiple platforms. This information may help you make smarter investment decisions.
About CYRX
Cryoport, Inc. (Cryoport), is a life sciences services company that is an integral part of the supply chain supporting the biopharma, reproductive medicine and animal health markets. Through its products and services the Company enable its clients to ship, store and deliver cellular-based materials and drug products as well as other life sciences commodities in a precise, defined temperature-controlled state. The Company’s advanced platform is comprised of comprehensive and technology-centric systems and solutions are designed to support the global high-volume distribution of commercial biologic and cell-based products and therapies regulated by the United States Food and Drug Administration (FDA) and other international regulatory bodies for distribution in the Americas, Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC) regions.
More